Angiotensin II upregulates CaV1.2 protein expression in cultured arteries via endothelial H2O2 production

Journal of Vascular Research

Volumn 48, Issue 1, 2010, Pages 67-78

  Wang, Wenze ^a   Pang, Li ^b   Palade, Philip ^b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

CaV1.2 Ca2+ channel; Endothelium; Reactive oxygen species; Vascular smooth muscle

Indexed keywords

4 (2 BENZYLBENZOYL) 2,5 DIMETHYL 1H PYRROLE 3 CARBOXYLIC ACID METHYL ESTER; ANGIOTENSIN II; APOCYNIN; DIPHENYLIODONIUM SALT; GP91DS TAT; HYDROGEN PEROXIDE; OXIDOREDUCTASE INHIBITOR; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; UNCLASSIFIED DRUG; VOLTAGE GATED CALCIUM CHANNEL;

ANIMAL CELL; ARTERY WALL; ARTICLE; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SIGNAL TRANSDUCTION; UPREGULATION; VASCULAR SMOOTH MUSCLE;

ANGIOTENSIN II; ANIMALS; CALCIUM CHANNELS, L-TYPE; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; HYDROGEN PEROXIDE; MALE; MEMBRANE GLYCOPROTEINS; MESENTERIC ARTERIES; MUSCLE, SMOOTH, VASCULAR; NADPH OXIDASE; RATS; RATS, SPRAGUE-DAWLEY; UP-REGULATION; VASOCONSTRICTOR AGENTS;

EID: 77954556945     PISSN: 10181172     EISSN: None     Source Type: Journal    
DOI: 10.1159/000318776     Document Type: Article

References (60)

1. Kim S, Iwao H: Molecular and cellular mechanisms of angiotension II-mediated cardiovascular and renal diseases. Pharmacol Rev 2000; 52: 11-34.
2. Macrez-Lepretre N, Morel JL, Mironneau J: Angiotensin II-mediated activation of L-type calcium channels involves phosphati-dylinositol hydrolysis-independent activation of protein kinase C in rat portal vein myocytes. J Pharmacol Exp Ther 1996; 278: 468-475.
3. V 1.2 channels in spontaneously hypertensive rats. Am J Hypertens 2006; 19: 823-831.
4. 2+ channel activity in angiotensin-hypertension. Hypertension 2003; 41: 1124-1130.
5. V 1.2 protein in cultured arteries. Eur J Pharmacol 2008; 599: 117-120.
6. Romero JC, Reckelhoff JF: Role of angioten-sin and oxidative stress in essential hypertension. Hypertension 1999; 34: 943-949.
7. Lüscher TF, Boulanger CM, Yang Z, Noll G, Dohi Y: Interactions between endothelium-derived relaxing and contracting factors in health and cardiovascular disease. Circulation 1993; 87(suppl V):36-44.
8. Doughan AK, Harrison DG, Dikalov SI: Molecular mechanisms of angiotensin II-medi-ated mitochondrial dysfunction: linking mi-tochondrial oxidative damage and vascular endothelial dysfunction. Circ Res 2008; 102: 488-496.
9. Gragasin FS, Xu Y, Arenas IA, Kainth N, Da-vidge ST: Estrogen reduces angiotensin II-induced nitric oxide synthase and NAD(P)H oxidasse expression in endothelial cells. Ar-terioscler Thromb Vasc Biol 2003; 23: 38-44.
10. phox subunit. J Biol Chem 2003; 278: 12094-12100.
11. Zhang H, Schmeisser A, Garlichs CD, Plotze K, Damme U, Mugge A, Daniel WG: Angio-tensin II-induced superoxide anion generation in human vascular endothelial cells: role of membrane-bound NADH-/NADPH-oxi-dases. Cardiovasc Res 1999; 44: 215-222.
12. Higashi M, Shimokawa H, Hattori T, Hiroki J, Mu kai Y, Morikawa K, Ichiki T, Takahashi S, Takeshita A: Long-term inhibition of Rho-kinase suppresses angiotensin II-induced cardiovascular hypertrophy in rats in vivo. Effect on endothelial NAD(P)H oxidase system. Circ Res 2003; 93: 767-775.
13. Kerr S, Brosnan MJ, McIntyre M, Reid JL, Dominiczak AF, Hamilton CA: Superoxide anion production is increased in a model of genetic hypertension. Role of the endotheli-um. Hypertension 1999; 33: 1353-1358.
14. Ungvari Z, Csiszar A, Kaminski PM, Wolin MS, Koller A: Chronic high pressure-induced arterial oxidative stress: involvement of protein kinase C-dependent NAD(P)H oxidase and local renin-angiotensin system. Am J Pathol 2004; 165: 219-226.
15. Yamagishi S, Nakamura K, Ueda S, Kato S, Imaizumi T: Pigment epithelium-derived factor (PEDF) blocks angiotensin II signaling in endothelial cells via suppression of NADPH oxidase: a novel anti-oxidative mechanism of PEDF. Cell Tissue Res 2005; 320: 437-445.
16. Jacobson GM, Dourron HM, Liu J, Carretero OA, Reddy DJ, AndrzejewskiT, Pagano PJ: Novel NAD(P)H oxidase inhibitor suppresses angioplasty-induced superoxide and neo-intimal hyperplasia of rat carotid artery. Circ Res 2003; 92: 637-643.
17. - and systolic blood pressure in mice. Circ Res 2001; 89: 408-414.
18. Zhou X, Bohlen HG, Miller SJ, Unthank JL: NAD(P)H oxidase-derived peroxide mediate elevated basal and impared flow-induced NO production in SHR mesenteric arteries in vivo. Am J Physiol 2008; 295:H1008-H1016.
19. Ogita H, Liao JK: Endothelial function and oxidative stress. Endothelium 2004; 11: 123-132.
20. Ray R, Shah AM: NADPH oxidase and endo-thelial cell function. Clin Sci 2005; 109: 217-226.
21. - and endothelium. J Vasc Res 2005; 43: 109-119.
22. Tsai C-T, Wang DL, Chen W-P, Hwang J-J, Hsieh C-S, Hsu K-L, Tsend C-D, Lai L-P, Tseng Y-Z, Lin J-L: Angiotensin II increases expression of a1C subunit of L-type calcium channel through a reactive oxygen species and cAMP response element-binding protein-dependent pathway in HL-1 myocytes. Circ Res 2007; 100: 1476-1485.
23. Araki H, Nishi K, Jougasaki M: Effects of thrombosis on vascular tone in rat mesenteric arteries with endothelium in vivo. Circ Res 1990; 67: 312-318.
24. Matsuki T, Beach JM, Klindt RL, Duling BR: Modification of vascular reactivity by alteration of intimal permeability: effect of TNF-a. Am J Physiol 1993; 264:H1847-H1853.
25. Randall MD, Kay AP, Hiley CR: Endotheli-um-dependent modulation of the pressor activity of arginine vasopressin in the isolated superior mesenteric arterial bed of the rat. Br J Pharmacol 1988; 95: 646-652.
26. Dikalov S, Griendling KK, Harrison DG: Measurement of reactive oxygen species in cardiovascular studies. Hypertension 2007; 49: 717-727.
27. A receptor-mediated generation of hydrogen peroxide. Am J Physiol 2005; 288:L480-L487.
28. Brandes RP: A radical adventure: the quest for specific functions and inhibitors of vascular NAPDH oxidases. Circ Res 2003; 92: 583-585.
29. Williams HC, Griendling KK: NADPH oxidase inhibitors: New antihypertensive agents? J Cardiovasc Pharmacol 2007; 50: 9-16.
30. Pinzar E, Wang T, Garrido MR, Xu W, Levy P, Bottari SP: Angiotensin II induces tyrosine nitration and activation of ERK1/2 in vascular smooth muscle cells. FEBS Lett 2005; 579: 5100-5104.
31. Rocic P, Seshiah P, Griendling KK: Reactive oxygen species sensitivity of angiotensin II-dependent translation initiation in vascular smooth muscle cells. J Biol Chem 2003; 278: 36973-36979.
32. Touyz RM, Schiffrin EL: Reactive oxygen species in vascular biology: implication in hypertension. Histochem Cell Biol 2004; 122: 339-352.
33. Virdis A, Neves MF, Amiri F, Touyz RM, Schiffrin EL: Role of NAD(P)H oxidase on vascular alterations in angiotensin II-in-fused mice. J Hyperten 2004; 22: 535-542.
34. Mollnau H, Wendt M, Szocs K, Lassegue B, Schulz E, Oelze M, Li H, Bodenschatz M, August M, Kleschyov AL, Tsilimingas N, Walter U, Forstermann U, Meinertz T, Griendling K, Munzel T: Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circ Res 2002; 90:e58-e65.
35. Touyz RM: Reactive oxygen species as mediators of calcium signaling by angiotensin II: implications in vascular physiology and pathophysiology. Antiox Redox Signal 2005; 7: 1302-1314.
36. Paravicini TM, Touyz RM: Redox signaling in hypertension. Cardiovasc Res 2006; 71: 247-258.
37. 2 production by a non-phagocytic NAD(P) H oxidase causes oxidant injury. J Biol Chem 2001; 276: 29251-29256.
38. V 1.2 iso-forms under the control of distinct 5' flank-ing regulatory elements. FEBS Lett 2003; 546: 349-354.
39. V 1.2 L-type calcium channel different from the principal heart form. Biochem Biophys Res Commun 2003; 302: 23-28.
40. V 1.2 transcripts in rat tissues mediated by different promoters. Cell Calcium 2005; 37: 301-309.
41. Colden-Stanfield M, Schilling WP, Ritchie AK, Eskin SG, Navarro LT, Kunze DL: Brady -kinin-induced increases in cytosolic calcium and ionic currents in cultured bovine aortic endothelial cells. Circ Res 1987; 61: 632-640.
42. Bossu JL, Elhamdani A, Feltz A, Tanzi F, Au-nis D, Thierse D: Voltage-gated Ca entry in isolated bovine capillary endothelial cells: evidence of a new type of BAY K 8644-sensitive channel. Pflugers Arch 1992; 420: 200-207.
43. Cai H, Li Z, Dikalov S, Holland SM, Hwang J, Jo H, Dudley SC, Harrison DG: NAD(P)H oxidase-derived hydrogen peroxide mediates endothelial nitric oxide production in response to angiotensin II. J Biol Chem 2002; 277: 48311-48317.
44. Mahrouf M, Ouslimani N, Peynet J, Djelidi R, Couturier M, Therond P, Legrand A, Beaudeux JL: Metformin reduces angioten-sin-mediated intracellular production of reactive oxygen species in endothelial cells through the inhibition of protein kinase C. Biochem Pharmacol 2006; 72: 176-183.
45. Gao Y, Lee RM: Hydrogen peroxide is an en-dothelium-dependent contracting factor in rat renal artery. Br J Pharmacol 2005; 146: 1061-1068.
46. 2 production. Br J Pharmacol 2001; 134: 1639-1646.
47. 2 in rat aorta. Vasc Pharmacol 2005; 43: 128-138.
48. Thakali K, Davenport L, Fink GD, Watts SW: Pleiotropic effects of hydrogen peroxide in arteries and veins from normotensive and hypertensive rats. Hypertension 2006; 47: 482-487.
49. Palen DI, Ouhtit A, Belmadani S, Lucchesi PA, Matrougui K: Hydrogen peroxide acts as relaxing factor in human vascular smooth muscle cells independent of map-kinase and nitric oxide. Front Biosci 2006; 11: 2526-2534.
50. Torrecillas G, Boyano-Adánez MDC, Medina J, Parra T, Griera M, López-Ongil S, Ar-illa E, Rodríguez-Puyol M, Rodríguez- Puyol D: The role of hydrogen peroxide in the contractile response to angiotensin II. Mol Pharmacol 2000; 59: 104-112.
51. Görlach A, Brandes AA, Nruyen K, Amidi M, Dehghani F, Busse R: A gp91phox containing NADPH oxidase selectively expressed in endothelial cells is a major source of oxygen radical generation in the arterial wall. Circ Res 2000; 87: 26-32.
52. 2+ channel function in the absence of apoptosis in ventricular myocytes. Circ Res 2007; 100: 1036-1044.
53. Dodd-o JM, Zheng G, Silverman HS, Lakatta EG, Ziegelstein RC: Endothelium-indepen-dent relaxation of aortic rings by the nitric oxide synthase inhibitor diphenyleneiodo-nium. Br J Pharmacol 1997; 120: 857-864.
54. Heumuller S, Wind S, Barbosa-Sicard E, Schmidt HHHW, Busee R, Schroder K, Brandes RP: Apocynin is not an inhibitor of vascular NADPH oxidases but an antioxi-dant. Hypertension 2008; 51: 211-217.
55. Weir EK, Wyatt CN, Reeve HL, Huang J, Archer SL, Peers C: Diphenyleneiodonium inhibits both potassium and calcium currents in isolated pulmonary artery smooth muscle cells. J Appl Physiol 1994; 76: 2611-2615.
56. Wang HD, Xu S, Johns DG, Du Y, Quinn MT, Cayatte AJ, Cohen RA: Role of NADPH oxi-dase in the vascular hypertrophic and oxida-tive stress response to a ngiotensin II in mice. Circ Res 2001; 88: 947-953.
57. Lai EY, Martinka P, Fahling M, Mrowka R, Steege A, Gericke A, Sendeski M, Persson PB, Patzak A: Adenosine restores angiotensin II-induced contractions by receptor-independent enhancement of calcium sensitivity in renal arterioles. Circ Res 2006; 99: 1117-1124.
58. 2+ -sensitivity of the contractile appa-raturs during angiotensin II-induced desen-sitization in the rabbit femoral artery. Br J Pharmacol 2000; 129: 425-436.
59. i in caninecere-bral arterial smooth muscle: participation of cellular signaling pathways. Naunyn Schmied Arch Pharmacol 1999; 360, 646-653.
60. Ardanaz N, Pagano PJ: Hydrogen peroxide as a paracrine vascular mediator: regulation and signaling leading to dysfunction. Exp Biol Med 2006; 231: 237-251.